GLIDAPA 3D 10/100/500 SR

GLIDAPA 3D 10/100/500 SR is a combination medication that includes Dapagliflozin 10 mg, Sitagliptin 100 mg, and Metformin SR 500 mg. This medication is specifically formulated for the management of type 2 diabetes. The synergistic effect of these three components helps in achieving better glycemic control for patients.

How Does It Work?

• Dapagliflozin: Works by inhibiting SGLT2, reducing glucose reabsorption in the kidneys, and promoting glucose excretion through urine.
• Sitagliptin: Enhances the levels of incretin hormones, which increases insulin release and decreases glucagon levels in the bloodstream.
• Metformin SR: Improves insulin sensitivity and reduces glucose production in the liver.

Uses of GLIDAPA 3D 10/100/500 SR

• Improves Glycemic Control: Helps in maintaining target blood glucose levels.
• Reduces HbA1c Levels: Lowers glycated hemoglobin, indicating better long-term blood sugar control.
• Weight Management: Aids in weight reduction as part of a comprehensive diabetes management plan.

What is GLIDAPA 3D 10/100/500 SR?

GLIDAPA 3D 10/100/500 SR is an oral antidiabetic medication designed to manage blood sugar levels in adults with type 2 diabetes. It combines three active ingredients to provide a multifaceted approach to diabetes care.

Side Effects

• Nausea

• Diarrhea

• Headache

• Urinary tract infections

• Lactic acidosis

• Severe hypoglycemia

• Pancreatitis

• Kidney problems

Safety Information

• Consult Your Doctor: Always seek medical advice before starting or changing dosage.
• Regular Monitoring: Regularly monitor blood sugar levels and renal function.
• Hydration: Ensure adequate fluid intake to prevent dehydration.
• Avoid Alcohol: Limit alcohol consumption as it can increase the risk of lactic acidosis.
• Pregnancy and Breastfeeding: Consult a healthcare provider as this medication may not be suitable.

If You Need More Information About  GLIDAPA 3D 10/100/500 SR: Click here